Screener
NeoGenomics NEO Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development | 10,761 | 9,023 | 20,295 | 19,204 |
| Sales and marketing | 27,275 | 24,075 | 51,105 | 46,758 |
| Impairment charges (Note 5) | — | 20,041 | — | 20,041 |
| Total operating expenses | 101,649 | 124,886 | 200,754 | 225,957 |
| LOSS FROM OPERATIONS | (9,771) | (47,628) | (28,012) | (75,453) |
| Interest income | 1,214 | 2,263 | 2,487 | 5,984 |
| Interest expense | (781) | (933) | (1,379) | (2,551) |
| Other (expense) income, net | (17) | 482 | (29) | 547 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's total operating expenses?
- NeoGenomics (NEO) reported total operating expenses of $101.65M in Q2 2026.
- How has NeoGenomics's total operating expenses changed year-over-year?
- NeoGenomics's total operating expenses decreased by 18.6% year-over-year, from $124.89M to $101.65M.
- What is the long-term trend for NeoGenomics's total operating expenses?
- Over 4 years (2021 to 2025), NeoGenomics's total operating expenses has grown at a 8.9% compound annual growth rate (CAGR), from $305.81M to $430.17M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about NeoGenomics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude